Covid-19 roundup: No­vavax de­lays US, Mex­i­co vac­cine tri­al (again); In­dia in­ves­ti­gates re­port­ed side ef­fects in As­traZeneca study

No­vavax is de­lay­ing the start of its US/Mex­i­co Phase III tri­al a sec­ond time, even as it com­pletes en­roll­ment for two oth­er stud­ies of its …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

Director of IT, Security

Viridian Therapeutics

Waltham, MA, USA